[go: up one dir, main page]

DK1066038T3 - Anvendelse af cabergolin ved behandling af retsless legs-syndrom - Google Patents

Anvendelse af cabergolin ved behandling af retsless legs-syndrom

Info

Publication number
DK1066038T3
DK1066038T3 DK99914882T DK99914882T DK1066038T3 DK 1066038 T3 DK1066038 T3 DK 1066038T3 DK 99914882 T DK99914882 T DK 99914882T DK 99914882 T DK99914882 T DK 99914882T DK 1066038 T3 DK1066038 T3 DK 1066038T3
Authority
DK
Denmark
Prior art keywords
cabergoline
treatment
legless
legs syndrome
syndrome
Prior art date
Application number
DK99914882T
Other languages
English (en)
Inventor
Peter Schueler
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1066038T3 publication Critical patent/DK1066038T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99914882T 1998-03-27 1999-03-24 Anvendelse af cabergolin ved behandling af retsless legs-syndrom DK1066038T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7963998P 1998-03-27 1998-03-27

Publications (1)

Publication Number Publication Date
DK1066038T3 true DK1066038T3 (da) 2006-04-24

Family

ID=22151836

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99914882T DK1066038T3 (da) 1998-03-27 1999-03-24 Anvendelse af cabergolin ved behandling af retsless legs-syndrom

Country Status (23)

Country Link
US (1) US6114326A (da)
EP (1) EP1066038B1 (da)
JP (1) JP2002507562A (da)
KR (1) KR100597517B1 (da)
CN (1) CN1303286A (da)
AT (1) ATE313326T1 (da)
AU (1) AU747751B2 (da)
BR (1) BR9908953A (da)
CA (1) CA2320204A1 (da)
CZ (1) CZ297284B6 (da)
DE (1) DE69929041T2 (da)
DK (1) DK1066038T3 (da)
EA (1) EA002554B1 (da)
ES (1) ES2255255T3 (da)
HU (1) HUP0101954A3 (da)
IL (1) IL138522A0 (da)
NO (1) NO20004799L (da)
NZ (1) NZ507176A (da)
PL (1) PL343593A1 (da)
SK (1) SK13312000A3 (da)
TR (1) TR200002759T2 (da)
WO (1) WO1999048484A2 (da)
ZA (1) ZA200004452B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
KR100417489B1 (ko) 1997-12-22 2004-02-05 유로-셀티크 소시에떼 아노뉨 오피오이드 효능제／길항제 혼합물
US6477408B1 (en) * 2000-03-07 2002-11-05 Northwestern University Analysis of muscular activity in neonatal animals to screen for mutations and/or drugs that alter sleep and wake states
GB0007309D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Crystalline form V|| of cabergoline
GB0007308D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
US6426713B1 (en) * 2000-07-05 2002-07-30 Cirrus Logic, Inc. Independent control of calibration registers in a multi channel A-D converter
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
AR031152A1 (es) 2000-10-31 2003-09-10 Upjohn Co Tratamientos nuevos para el sindrome de piernas inquietas
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20020123503A1 (en) * 2000-12-21 2002-09-05 Malcolm Ross Cabergoline pharmaceutical compositions and methods of use thereof
DE60231388D1 (de) 2001-03-30 2009-04-16 Toray Industries Mittel zur behandlung des syndroms der unruhigen beine
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
US20030134844A1 (en) * 2001-10-31 2003-07-17 Pfizer Inc. Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome
US20030176822A1 (en) * 2002-03-12 2003-09-18 Morgenlander Joel C. Method of treating restless leg syndrome
DE20308436U1 (de) * 2002-04-05 2003-09-18 Euroceltique S.A., Luxemburg/Luxembourg Lagerstabiles pharmazeutisches Präparat, das Oxycodon und Naloxon umfasst
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
ES2310258T5 (es) 2002-08-30 2012-05-31 Kyowa Hakko Kogyo Co., Ltd. Antagonistas de los receptores de adenosina A2A para tratar el síndrome de piernas inquietas o mioclono nocturno
MXPA06003043A (es) 2003-09-17 2006-05-31 Xenoport Inc Tratamiento o prevencion del sindrome piernas inquietas utilizando prodrogas de analogos gaba.
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
KR20060030175A (ko) * 2004-10-05 2006-04-10 경북대학교 산학협력단 무정위성 운동 치료용 약학조성물
US20070259045A1 (en) * 2005-01-28 2007-11-08 Euro-Celtique S.A. Alcohol Resistant Dosage Forms
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
DK1984344T3 (da) * 2005-12-29 2013-01-14 Lexicon Pharmaceuticals Inc Multicykliske aminosyrederivater og fremgangsmåder til anvendelse heraf
JP5769923B2 (ja) * 2006-04-03 2015-08-26 テバ ファーマシューティカル インダストリーズ リミティド レストレスレッグス症候群の治療のためのラサギリンの使用
WO2008046149A1 (en) * 2006-10-17 2008-04-24 Biologic Health Solutions Pty Ltd Herbal compositions for the prevention or treatment of restless leg syndrome
EP1952813A1 (en) * 2007-02-01 2008-08-06 Ferring International Center S.A. Medicament for the treatment of endometriosis
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
US7939665B2 (en) 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
EP2083008A1 (en) * 2007-12-07 2009-07-29 Axxonis Pharma AG Ergoline derivatives as selective radical scavengers for neurons
ES2706407T3 (es) 2009-03-10 2019-03-28 Euro Celtique Sa Composiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona
CN102448444B (zh) 2009-04-01 2016-05-25 巴尔-波特拉及康邦亚股份有限公司 包括硝基儿茶酚衍生物的药物制剂及其制备方法
US8690933B2 (en) * 2009-08-31 2014-04-08 Brigham Young University System and method for treating symptoms of restless legs syndrome
US20140045900A1 (en) 2011-02-11 2014-02-13 Bial-Portela & Ca, S.A. Administration regime for nitrocatechols
US10071089B2 (en) 2013-07-23 2018-09-11 Euro-Celtique S.A. Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
PL232974B1 (pl) * 2015-12-09 2019-08-30 Ofta Spolka Z Ograniczona Odpowiedzialnoscia Zastosowanie agonistów receptorów dopaminergicznych typu 2 w leczeniu schorzeń oczu wywołanych przez podwyższony poziom śródbłonkopochodnego czynnika wzrostu naczyń
WO2018129351A1 (en) 2017-01-05 2018-07-12 Shriram Raghunathan Restless leg syndrome or overactive nerve treatment
WO2021067751A1 (en) 2019-10-03 2021-04-08 Noctrix Health, Inc. Peripheral nerve stimulation for restless legs syndrome
EP4041376A1 (en) 2019-10-03 2022-08-17 Noctrix Health, Inc. Peripheral nerve stimulation for restless legs syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526892A (en) * 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
US5496836A (en) * 1994-05-05 1996-03-05 Mount Sinai School Of Medicine Of The City University Of New York Use of famotidine and related compounds in the treatment of movement disorders

Also Published As

Publication number Publication date
HUP0101954A2 (hu) 2001-12-28
CZ20003419A3 (cs) 2002-01-16
AU747751B2 (en) 2002-05-23
NZ507176A (en) 2003-09-26
CA2320204A1 (en) 1999-09-30
PL343593A1 (en) 2001-08-27
NO20004799D0 (no) 2000-09-26
EP1066038B1 (en) 2005-12-21
DE69929041T2 (de) 2006-07-20
AU3353199A (en) 1999-10-18
CZ297284B6 (cs) 2006-10-11
JP2002507562A (ja) 2002-03-12
WO1999048484A2 (en) 1999-09-30
EA002554B1 (ru) 2002-06-27
HUP0101954A3 (en) 2002-09-30
BR9908953A (pt) 2000-12-05
ES2255255T3 (es) 2006-06-16
EP1066038A2 (en) 2001-01-10
DE69929041D1 (de) 2006-01-26
US6114326A (en) 2000-09-05
ATE313326T1 (de) 2006-01-15
SK13312000A3 (sk) 2001-05-10
IL138522A0 (en) 2001-10-31
WO1999048484A3 (en) 1999-11-25
CN1303286A (zh) 2001-07-11
KR100597517B1 (ko) 2006-07-10
ZA200004452B (en) 2002-02-27
EA200000994A1 (ru) 2001-02-26
TR200002759T2 (tr) 2001-02-21
NO20004799L (no) 2000-10-11
KR20010052222A (ko) 2001-06-25

Similar Documents

Publication Publication Date Title
DK1066038T3 (da) Anvendelse af cabergolin ved behandling af retsless legs-syndrom
MXPA03003912A (es) Tratamientos nuevos para el sindrome de piernas inquietas.
ATE424413T1 (de) Analoge des glucagon-ähnlichen peptids-1
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
NO20005928L (no) Bicykliske pyrimidiner og bicykliske 3,4-dihydropyrimidiner som inhibitorer av cellulær proliferasjon
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
DK1274430T3 (da) Cabergolin til behandling af fibromyalgi og kronisk trathedssyndrom
DK0967987T3 (da) Sammensætning til behandling af tumorer indeholdende hajbruskekstrakter og anitneoplastiske stoffer
DK1411916T3 (da) Fremgangsmåder og materialer til behandling af testosteronmangel hos mænd
NO20031860D0 (no) Kahalaolid F
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
DK1441761T3 (da) Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr
ZA98420B (en) Use of pramipexole in the treatment of restless legs syndrome.
SE0302361D0 (sv) Inhibering av upptagning av monoamin
NO20005548L (no) Mykobakterieinhibitorer
DK1272456T3 (da) Angioneseinhibitorer på basis af hydrazid og alkoxyamid
GEP20074097B (en) Use of specific dose of fondaparinux sodium for the treatment of acs
DK1500396T3 (da) Reboxetin til behandling af migrænehovedpiner
NO20000649L (no) Dielektriske komponenter for höyfrekvens, og apparater med slike
IT1309840B1 (it) Accessorio per il sostegno di calzini, gambaletti, calze e manufattianaloghi anche se privi di elastico.
ITPI990011U1 (it) Accessorio per il sostegno di calzini, gambaletti, calze e manufattianaloghi anche se privi di elastico.
IT237515Y1 (it) Lettino trasportabile particolarmente studiato per massaggi e perfisioterapisti
ITPD990199A1 (it) Tavolo da gioco e procedimento di gioco preferito
ES1048097Y (es) Cenicero perfeccionado polivalente con apagacigarrillos y cigarros puros.
KR970059447U (ko) 안경다리용 개량 귀걸이구